AKT1 and prostate carcinoma: KEGG pathway enrichment revealed that cancer-related pathways were widely enriched, with the Prostate cancer pathway ranking first, indicating that SR-CR AKT1, mTOR, and CASP9 were all enriched in the Prostate cancer pathway.